Umit Haluk Iliklerden
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Umit Haluk Iliklerden has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Çetin Kotan
Van Yuzuncu Yil Universitesi
4 shared publications - Serhat Binici
Department of General Surgery, Faculty of Medicine, Van Yüzüncü Yıl University, 65090 Van, Türkiye
3 shared publications - Tolga Kalayci
AĞRI İBRAHİM ÇEÇEN ÜNİVERSİTESİ, TIP FAKÜLTESİ, CERRAHİ TIP BİLİMLERİ BÖLÜMÜ, GENEL CERRAHİ ANABİLİM DALI
3 shared publications - Abdullah Sakin
Department of Medical Oncology, Prof. Dr. Cemil Taşcioğlu City Hospital, Istanbul, Turkey
2 shared publications - Abdulselam Özdemir
Department of General Surgery, Selahattin Eyyübi State Hospital, 21100 Diyarbakır, Türkiye
2 shared publications - Burhan Beger
Department of Pediatric Surgery, Van Yüzüncü Yıl University Faculty of Medicine, 65080 Van, Türkiye
2 shared publications
Latest Publications
- Open Access
- 17 March 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (3) , 698
Antifibrotic Effect of the TGF-β Type I Receptor Inhibitor EW-7197 on Anastomotic Healing in a Rat Choledochojejunostomy Model
Background/Aim: Anastomotic stricture following choledochojejunostomy (CJS) is largely driven by fibrotic remodeling at the anastomotic site, a process mediated by transforming growth factor-β (TGF-β) signaling. This problem is particularly relevant in emergency biliary surgery, where CJS is frequently performed under suboptimal conditions and anastomotic leakage is common, predisposing to exaggerated fibrosis and late strictures. This study aimed to evaluate the effect of the TGF-β type I receptor (ALK5) inhibitor EW-7197 (vactosertib) on histopathological parameters of anastomotic healing, with a particular focus on fibrosis, in a rat CJS model. Materials and Methods: Twenty-four male Wistar Albino rats were randomized into three groups (n = 8 each): control (G1), CJS only (G2), and CJS plus EW-7197 (G3). EW-7197 was administered as a single intraperitoneal dose (20 mg/kg) immediately after completion of the anastomosis. On postoperative day 21, choledochojejunal anastomotic tissues were harvested and evaluated histologically using hematoxylin–eosin and Masson’s trichrome staining. Edema, hyperemia, inflammation, and fibrosis were graded using a semi-quantitative scoring system, and intergroup comparisons were performed using non-parametric statistical tests. Results: Compared with surgery alone, EW-7197 treatment resulted in a statistically significant reduction in fibrosis severity at the anastomotic site (p < 0.001) and a significant attenuation of hyperemia (p = 0.007). Edema scores showed a downward trend in the EW-7197-treated group but did not reach statistical significance, while inflammation scores did not differ significantly between the surgical groups. Conclusions: In this experimental rat choledochojejunostomy model, administration of the selective ALK5 inhibitor EW-7197 significantly reduced histopathological fibrosis and hyperemia at the anastomotic site on postoperative day 21 without affecting inflammation severity. These findings support the role of the TGF-β/Smad pathway in bilioenteric anastomotic fibrotic remodeling. However, further studies including molecular validation and functional assessments are required to clarify the translational relevance of these results.
- 17 March 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (3) , 698
Open AccessAntifibrotic Effect of the TGF-β Type I Receptor Inhibitor EW-7197 on Anastomotic Healing in a Rat Choledochojejunostomy Model
Background/Aim: Anastomotic stricture following choledochojejunostomy (CJS) is largely driven by fibrotic remodeling at the anastomotic site, a process mediated by transforming growth factor-β (TGF-β) signaling. This problem is particularly relevant in emergency biliary surgery, where CJS is frequently performed under suboptimal conditions and anastomotic leakage is common, predisposing to exaggerated fibrosis and late strictures. This study aimed to evaluate the effect of the TGF-β type I receptor (ALK5) inhibitor EW-7197 (vactosertib) on histopathological parameters of anastomotic healing, with a particular focus on fibrosis, in a rat CJS model. Materials and Methods: Twenty-four male Wistar Albino rats were randomized into three groups (n = 8 each): control (G1), CJS only (G2), and CJS plus EW-7197 (G3). EW-7197 was administered as a single intraperitoneal dose (20 mg/kg) immediately after completion of the anastomosis. On postoperative day 21, choledochojejunal anastomotic tissues were harvested and evaluated histologically using hematoxylin–eosin and Masson’s trichrome staining. Edema, hyperemia, inflammation, and fibrosis were graded using a semi-quantitative scoring system, and intergroup comparisons were performed using non-parametric statistical tests. Results: Compared with surgery alone, EW-7197 treatment resulted in a statistically significant reduction in fibrosis severity at the anastomotic site (p < 0.001) and a significant attenuation of hyperemia (p = 0.007). Edema scores showed a downward trend in the EW-7197-treated group but did not reach statistical significance, while inflammation scores did not differ significantly between the surgical groups. Conclusions: In this experimental rat choledochojejunostomy model, administration of the selective ALK5 inhibitor EW-7197 significantly reduced histopathological fibrosis and hyperemia at the anastomotic site on postoperative day 21 without affecting inflammation severity. These findings support the role of the TGF-β/Smad pathway in bilioenteric anastomotic fibrotic remodeling. However, further studies including molecular validation and functional assessments are required to clarify the translational relevance of these results.
- 28 January 2024
- Published by Springer Nature in Histochemistry and Cell Biology
- Vol. 161 (5) , 381-389
Addressing radiotherapy-induced fibrosis: the potential of platelet-rich plasma and infliximab for improved breast cancer management
Breast cancer treatment encompasses various therapeutic modalities, including surgery, radiotherapy, and chemotherapy. Breast-conserving surgery has been an integral part of breast cancer management. However, radiotherapy, an important component of breast cancer management, can lead to complications, particularly fibrosis, affecting reconstructive surgery outcomes. We conducted an in vivo study using 48 female Wistar Albino rats, employing segmental mastectomy and radiotherapy to simulate post-mastectomy conditions. The rats were divided into six groups: control, mastectomy, mastectomy + radiotherapy, mastectomy + platelet-rich plasma (PRP) + radiotherapy, mastectomy + infliximab + radiotherapy, and mastectomy + infliximab + PRP + radiotherapy. Edema, hyperemia, inflammation, and fibrosis were assessed as indicators of tissue response. Histopathological analysis revealed that mastectomy + infliximab and mastectomy + infliximab + PRP groups showed significant reductions in fibrosis compared to other groups. Edema, hyperemia, and inflammation were also less severe in these groups compared to the control group. Radiotherapy-induced fibrosis is a major concern in breast reconstruction. Our study suggests that local PRP application and systemic infliximab administration, either alone or in combination, could mitigate the adverse effects of radiotherapy. This approach has the potential to improve reconstructive outcomes in patients undergoing or having the possibility to undergo radiotherapy. This is the first study showing the effectiveness of infliximab and PRP combination on wound healing. The provided experimental rat model might offer guidance for further research. This study provides insights into optimizing outcomes in reconstructive breast surgery, paving the way for further research and clinical studies.
- 28 January 2024
- Published by Springer Nature in Histochemistry and Cell Biology
- Vol. 161 (5) , 381-389
Addressing radiotherapy-induced fibrosis: the potential of platelet-rich plasma and infliximab for improved breast cancer management
Breast cancer treatment encompasses various therapeutic modalities, including surgery, radiotherapy, and chemotherapy. Breast-conserving surgery has been an integral part of breast cancer management. However, radiotherapy, an important component of breast cancer management, can lead to complications, particularly fibrosis, affecting reconstructive surgery outcomes. We conducted an in vivo study using 48 female Wistar Albino rats, employing segmental mastectomy and radiotherapy to simulate post-mastectomy conditions. The rats were divided into six groups: control, mastectomy, mastectomy + radiotherapy, mastectomy + platelet-rich plasma (PRP) + radiotherapy, mastectomy + infliximab + radiotherapy, and mastectomy + infliximab + PRP + radiotherapy. Edema, hyperemia, inflammation, and fibrosis were assessed as indicators of tissue response. Histopathological analysis revealed that mastectomy + infliximab and mastectomy + infliximab + PRP groups showed significant reductions in fibrosis compared to other groups. Edema, hyperemia, and inflammation were also less severe in these groups compared to the control group. Radiotherapy-induced fibrosis is a major concern in breast reconstruction. Our study suggests that local PRP application and systemic infliximab administration, either alone or in combination, could mitigate the adverse effects of radiotherapy. This approach has the potential to improve reconstructive outcomes in patients undergoing or having the possibility to undergo radiotherapy. This is the first study showing the effectiveness of infliximab and PRP combination on wound healing. The provided experimental rat model might offer guidance for further research. This study provides insights into optimizing outcomes in reconstructive breast surgery, paving the way for further research and clinical studies.
- Open Access
- 30 April 2023
- Published by Van Yuzuncu Yil University in Van Sağlık Bilimleri Dergisi
- Vol. 16 (1) , 1-8
Comparison of Pressure Resistances of Different Esophagogastric Anastomosis Techniques: An Ex Vivo Ovine Model Study
Background: Current anastomosis techniques including conventional esophageal (CEAT) and region expanding anastomosis techniques (REAT) in esophagus cancer surgeries have high mortality and morbidity rates, which underlines the lack of a golden standard method. Anastomosis techniques are one of responsible factors for stricture formation. In this regard, the study conducted on ex vivo ovine tissues was aimed to compare pressure resistances of different anastomosis techniques in term of stricture formation. Methods: Thirty-five esophagus and gastric samples from 35 male lambs aged 12 months were used ex vivo for the study. Samples were divided into 5 groups according to anastomosis techniques including Hand-Made Sutured Technique (HM), Circular Stapler Sutured Technique (CS), Reinforced Circular Stapler Sutured Technique (rCS), Modified Plus “+” Incision Technique (mP+IT), and Modified Arrow-Bow Hand-Made Sutured Technique (mabHM). The intraluminal pressure resistance of the CEAT (e.g. the HM, CS and rCS) and REAT (e.g. the mP+IT and mabHM) were recorded. Results: The pressures of different incision techniques from the highest to the lowest were found as follows: the rCS (114.71±3.77 cm H2O) > the CS (95.43±3.45 cm H2O) > the HM (84.14±3.67cm H2O) > the mabHM (79.71±2.87 cm H2O) > the mP+IT (77.14±6.23 cm H2O) (p < 0.001). Except the comparison of the HM versus the mabHM (p=0.558), and the mP+IT versus the mabHM, the other techniques differ statistically significantly from each other. Conclusion: In our study, the durability of anastomoses using CEAT was found to be higher and compatible with the literature. Although in vivo live animal studies are necessary, REAT can be safely used to prevent the development of stricture, which is the second most common complication of esophagogastric anastomoses. Our findings suggest that the CEAT especially the rCS can be safely administered to prevent leakage.
- 30 April 2023
- Published by Van Yuzuncu Yil University in Van Sağlık Bilimleri Dergisi
- Vol. 16 (1) , 1-8
Open AccessComparison of Pressure Resistances of Different Esophagogastric Anastomosis Techniques: An Ex Vivo Ovine Model Study
Background: Current anastomosis techniques including conventional esophageal (CEAT) and region expanding anastomosis techniques (REAT) in esophagus cancer surgeries have high mortality and morbidity rates, which underlines the lack of a golden standard method. Anastomosis techniques are one of responsible factors for stricture formation. In this regard, the study conducted on ex vivo ovine tissues was aimed to compare pressure resistances of different anastomosis techniques in term of stricture formation. Methods: Thirty-five esophagus and gastric samples from 35 male lambs aged 12 months were used ex vivo for the study. Samples were divided into 5 groups according to anastomosis techniques including Hand-Made Sutured Technique (HM), Circular Stapler Sutured Technique (CS), Reinforced Circular Stapler Sutured Technique (rCS), Modified Plus “+” Incision Technique (mP+IT), and Modified Arrow-Bow Hand-Made Sutured Technique (mabHM). The intraluminal pressure resistance of the CEAT (e.g. the HM, CS and rCS) and REAT (e.g. the mP+IT and mabHM) were recorded. Results: The pressures of different incision techniques from the highest to the lowest were found as follows: the rCS (114.71±3.77 cm H2O) > the CS (95.43±3.45 cm H2O) > the HM (84.14±3.67cm H2O) > the mabHM (79.71±2.87 cm H2O) > the mP+IT (77.14±6.23 cm H2O) (p < 0.001). Except the comparison of the HM versus the mabHM (p=0.558), and the mP+IT versus the mabHM, the other techniques differ statistically significantly from each other. Conclusion: In our study, the durability of anastomoses using CEAT was found to be higher and compatible with the literature. Although in vivo live animal studies are necessary, REAT can be safely used to prevent the development of stricture, which is the second most common complication of esophagogastric anastomoses. Our findings suggest that the CEAT especially the rCS can be safely administered to prevent leakage.
- 1 May 2022
- Published by Ordu University in Black Sea Journal of Health Science
- Vol. 5 (2) , 168-173
Factors Affecting Morbidity and Mortality in Gastrectomy Cases with Splenectomy
Gastric cancer is a worldwide health problem. The addition of splenectomy to gastrectomy is a controversial issue, especially in cases located on the greater curvature. In this study, it is aimed to find the factors affecting morbidity and mortality in gastrectomy cases with splenectomy. Patients who underwent surgery for gastric cancer in Van Yuzuncu Yil University, Department of General Surgery between January 2010 and January 2018 were retrospectively selected. Splenectomy cases were filtered out in all gastrectomy patients. Preoperative, intraoperative and postoperative data of the patients were collected. The effects of the collected parameters on morbidity and mortality were evaluated. A p value of less than 0.05 was considered statistically significant. 45 patients were included in the study. The mean age of all patients was 64.2 years (32-85) and the male to female ratio was 27/18. Thirty seven cases (82.2%) were operated under elective conditions. The most common tumor location was cardia (n=24, 53.3%) and the most common surgical method (n=39) was total gastrectomy (86.7%). Morbidity and mortality rate of the study were 46.6% (n=21) and 17.8% (n=8), respectively. Mortality increased in patients who were operated in emergency conditions and received neoadjuvant therapy, p=0.002 and P=0.044, respectively. While surgery under emergency conditions increased mortality, preoperative neoadjuvant treatment decreased mortality. However, there was no factor affecting morbidity. Splenectomy in gastric cancer surgery, if possible, should be performed under elective conditions and after neoadjuvant therapy to reduce mortality
- 1 May 2022
- Published by Ordu University in Black Sea Journal of Health Science
- Vol. 5 (2) , 168-173
Factors Affecting Morbidity and Mortality in Gastrectomy Cases with Splenectomy
Gastric cancer is a worldwide health problem. The addition of splenectomy to gastrectomy is a controversial issue, especially in cases located on the greater curvature. In this study, it is aimed to find the factors affecting morbidity and mortality in gastrectomy cases with splenectomy. Patients who underwent surgery for gastric cancer in Van Yuzuncu Yil University, Department of General Surgery between January 2010 and January 2018 were retrospectively selected. Splenectomy cases were filtered out in all gastrectomy patients. Preoperative, intraoperative and postoperative data of the patients were collected. The effects of the collected parameters on morbidity and mortality were evaluated. A p value of less than 0.05 was considered statistically significant. 45 patients were included in the study. The mean age of all patients was 64.2 years (32-85) and the male to female ratio was 27/18. Thirty seven cases (82.2%) were operated under elective conditions. The most common tumor location was cardia (n=24, 53.3%) and the most common surgical method (n=39) was total gastrectomy (86.7%). Morbidity and mortality rate of the study were 46.6% (n=21) and 17.8% (n=8), respectively. Mortality increased in patients who were operated in emergency conditions and received neoadjuvant therapy, p=0.002 and P=0.044, respectively. While surgery under emergency conditions increased mortality, preoperative neoadjuvant treatment decreased mortality. However, there was no factor affecting morbidity. Splenectomy in gastric cancer surgery, if possible, should be performed under elective conditions and after neoadjuvant therapy to reduce mortality
- 19 April 2022
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 85 (2) , 301-306
New Diagnostic Biomarker-Soluble Erythropoietin-producing hepatocellular receptor A2 (EphA2) for colon cancer
- 19 April 2022
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 85 (2) , 301-306
New Diagnostic Biomarker-Soluble Erythropoietin-producing hepatocellular receptor A2 (EphA2) for colon cancer
- 5 October 2021
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 84 (1) , 164-169
The Role of Latent Transforming Growth Factor β Binding Protein 2 (LTBP2) in the Diagnosis and Stage Discrimination of Gastric Cancer
- 5 October 2021
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 84 (1) , 164-169
The Role of Latent Transforming Growth Factor β Binding Protein 2 (LTBP2) in the Diagnosis and Stage Discrimination of Gastric Cancer
- Open Access
- 31 March 2021
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 53 (2) , 439-445
Factors Affecting Survival in Operated Esophageal Squamous Cell Carcinoma
Purpose Esophageal squamous cell carcinoma (ESCC) is an extremely fatal and relatively rare gastrointestinal system malignancy. This study aimed to investigate the factors affecting survival in operated patients with ESCC. Materials and Methods We included 110 patients (38 [34.5%] male; 72 [65.5%] female) aged ≥ 18 (median age, 54 [26–77]) years who were operated without any signs of metastases and followed up at Van Yüzüncü Yıl University Dursun Odabaşı Medical Center between 2004 and 2019. Results Initially, 39 (35.5%) patients were clinical lymph node-positive and 71 (64.5%) patients were negative. Thirty-five (31.8%) patients underwent surgery after neoadjuvant chemoradiotherapy (nCRT), and 75 (%68.2) patients underwent direct surgery without nCRT. Five-year overall survival (OS) was 84.4% and 59.2% in patients who underwent surgery after nCRT and in those who underwent direct surgery, respectively. Median OS was significantly longer in patients who underwent surgery after nCRT (p = 0.003). There was a statistically significant difference in OS in patients who underwent surgery after nCRT depending on tumor response (p = 0.04). In multivariate analysis, advanced pathologic stage (p = 0.002) adversely affected survival, whereas nCRT administration (p = 0.031) positively affected OS. Conclusion We suggest that nCRT should be administrated before surgery, especially in locally advanced ESCCs. In addition, we believe that nCRT response can be used as a good parameter for survival. These results, however, should be supported by prospective studies.
- 31 March 2021
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 53 (2) , 439-445
Open AccessFactors Affecting Survival in Operated Esophageal Squamous Cell Carcinoma
Purpose Esophageal squamous cell carcinoma (ESCC) is an extremely fatal and relatively rare gastrointestinal system malignancy. This study aimed to investigate the factors affecting survival in operated patients with ESCC. Materials and Methods We included 110 patients (38 [34.5%] male; 72 [65.5%] female) aged ≥ 18 (median age, 54 [26–77]) years who were operated without any signs of metastases and followed up at Van Yüzüncü Yıl University Dursun Odabaşı Medical Center between 2004 and 2019. Results Initially, 39 (35.5%) patients were clinical lymph node-positive and 71 (64.5%) patients were negative. Thirty-five (31.8%) patients underwent surgery after neoadjuvant chemoradiotherapy (nCRT), and 75 (%68.2) patients underwent direct surgery without nCRT. Five-year overall survival (OS) was 84.4% and 59.2% in patients who underwent surgery after nCRT and in those who underwent direct surgery, respectively. Median OS was significantly longer in patients who underwent surgery after nCRT (p = 0.003). There was a statistically significant difference in OS in patients who underwent surgery after nCRT depending on tumor response (p = 0.04). In multivariate analysis, advanced pathologic stage (p = 0.002) adversely affected survival, whereas nCRT administration (p = 0.031) positively affected OS. Conclusion We suggest that nCRT should be administrated before surgery, especially in locally advanced ESCCs. In addition, we believe that nCRT response can be used as a good parameter for survival. These results, however, should be supported by prospective studies.
- 1 January 2021
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 17 (1) , 15-20
Relationship Between Proliferative Breast Lesions and Breast Cancer Risk Factors
Objective: The prognosis of breast cancer (BC) is determined directly based on the stage of disease at the time of diagnosis. Proliferative breast lesions (PBLs) are an important risk factor for BC development. The risk of developing BC varies according to the presence of extent of proliferation in the breast lesions. We aimed to investigate the effect of BC risk factors on the PBLs in this study. Materials and Methods: Patients who visited the surgical clinic of the university during the past 6 years who presented with PBLs with or without atypia by fine/core needle aspiration biopsy were included in this study. The relationship between PBLs and BC risk factors such as the age, mass size, Body Mass index (BMI), smoking, sports activity, BC family history, the use of hormone replacement therapy, number of pregnancies, and the duration of breastfeeding were compared. Results: A total of 74 (96.1%) of all patients were women and three were men. The median age of the patients was 38 (range: 19-74) years; the cut-off value of age was 35.5 years. The mean age of patients with PBL-with atypia (PBL-WA) was higher (p=0.005) in the malignant group based on the final pathology and radiological imaging features (for both, p<0.001). The mean size of the mass was large at 2.53 +/- 1.33 (1-6) cm; and the cut-off value of the tumor size was 2.5 cm. The mean size was greater in the PBL-WA patients (p=0.171) in the malignant group based on the final pathology and radiological characteristic (respectively, p=0.004 and p=0.016). The mean BMI was 26.8 +/- 4.4 kg/m(2) (18.8-35.1) and the cut-off value was 25.4 kg/m(2). BMI was greater in the PBL-WA group and in the malignant group based on the final pathology (respectively, p=0.002 and p=0.001). Smoking was positive in 66.2% (n=51) of the patients, and it was high in the PBL-WA patients (p=0.001). The percentage of patients with no sports activity was 63.6% (n=49), while it was 20.8% (n=16) for those with once a week sports activity and 15.6% (n=12) for those with twice a week activity. There was family history of BC in 16.9% (n=13) of all patients. The number of positive cases of family history of BC was greater in the malignant group (p=0.001). Hormone replacement therapy was recorded in 11.7% (n=9) of the patients. The mean numbers of pregnancies (2.1 +/- 2.4) and breastfeeding duration (32.5 +/- 37.4 months) were low in the benign groups due to the relatively lower average age of the patients. Conclusion: Based on our analysis, age is an extremely important aspect for assessing PBLs. The age of the patient was statistically significantly greater in the patients with malignant lesions in all groups. The factors lesion size, BMI, smoking habit, and BC family history were also more frequent in the malignant groups. The rate of sports activity was lower in the malignant groups. Thus, it is necessary to evaluate patients individually when evaluating PBLs. It is recommended to evaluate PBLs together with BC risk factors for the better understanding.
- 1 January 2021
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 17 (1) , 15-20
Relationship Between Proliferative Breast Lesions and Breast Cancer Risk Factors
Objective: The prognosis of breast cancer (BC) is determined directly based on the stage of disease at the time of diagnosis. Proliferative breast lesions (PBLs) are an important risk factor for BC development. The risk of developing BC varies according to the presence of extent of proliferation in the breast lesions. We aimed to investigate the effect of BC risk factors on the PBLs in this study. Materials and Methods: Patients who visited the surgical clinic of the university during the past 6 years who presented with PBLs with or without atypia by fine/core needle aspiration biopsy were included in this study. The relationship between PBLs and BC risk factors such as the age, mass size, Body Mass index (BMI), smoking, sports activity, BC family history, the use of hormone replacement therapy, number of pregnancies, and the duration of breastfeeding were compared. Results: A total of 74 (96.1%) of all patients were women and three were men. The median age of the patients was 38 (range: 19-74) years; the cut-off value of age was 35.5 years. The mean age of patients with PBL-with atypia (PBL-WA) was higher (p=0.005) in the malignant group based on the final pathology and radiological imaging features (for both, p<0.001). The mean size of the mass was large at 2.53 +/- 1.33 (1-6) cm; and the cut-off value of the tumor size was 2.5 cm. The mean size was greater in the PBL-WA patients (p=0.171) in the malignant group based on the final pathology and radiological characteristic (respectively, p=0.004 and p=0.016). The mean BMI was 26.8 +/- 4.4 kg/m(2) (18.8-35.1) and the cut-off value was 25.4 kg/m(2). BMI was greater in the PBL-WA group and in the malignant group based on the final pathology (respectively, p=0.002 and p=0.001). Smoking was positive in 66.2% (n=51) of the patients, and it was high in the PBL-WA patients (p=0.001). The percentage of patients with no sports activity was 63.6% (n=49), while it was 20.8% (n=16) for those with once a week sports activity and 15.6% (n=12) for those with twice a week activity. There was family history of BC in 16.9% (n=13) of all patients. The number of positive cases of family history of BC was greater in the malignant group (p=0.001). Hormone replacement therapy was recorded in 11.7% (n=9) of the patients. The mean numbers of pregnancies (2.1 +/- 2.4) and breastfeeding duration (32.5 +/- 37.4 months) were low in the benign groups due to the relatively lower average age of the patients. Conclusion: Based on our analysis, age is an extremely important aspect for assessing PBLs. The age of the patient was statistically significantly greater in the patients with malignant lesions in all groups. The factors lesion size, BMI, smoking habit, and BC family history were also more frequent in the malignant groups. The rate of sports activity was lower in the malignant groups. Thus, it is necessary to evaluate patients individually when evaluating PBLs. It is recommended to evaluate PBLs together with BC risk factors for the better understanding.
- Open Access
- 1 January 2021
- Published by Kare Publishing in Turkish Journal of Trauma and Emergency Surgery
- Vol. 27 (2) , 222-230
Treatment of rectus sheath hematomas: 8 years of single center experience with a review of literature
BACKGROUND: Rectus sheath hematoma is a rare and frequently misdiagnosed cause of acute abdominal pain. In the management of the patients with rectus sheath hematoma, which are mostly with advanced age and comorbid diseases, positive results can be obtained by avoiding unnecessary surgical procedures with correct diagnosis and treatment approaches. The presented study aims to contribute to the lack of algorithms and optimal treatment strategies in the management of rectus sheath hematoma patients with the description of our experience in their management. METHODS: Patients who underwent treatment with the diagnosis of rectus sheath hematoma between May 2010 and July 2018 were retrospectively analyzed. Demographic characteristics, medical histories, physical and laboratory findings and imaging methods, treatment processes, complications, morbidity, mortality, length of hospitalization and long-term follow-up results were searched. Data were analyzed from patient files, hospital computer registry system and radiology archives. Data analysis was performed using Microsoft Excel and IBM-SPSS-Statistics-24. RESULTS: The mean age of the 31 patients was 63.03 years (24-85 years). The female/male ratio (21/10) was 2.1. The most common presenting sign or symptom was abdominal pain (100%), followed by abdominal wall mass in 25 patients (80.6%). Twenty-five patients (80.6%) were receiving some form of anticoagulation and antiplatelet therapy. Diagnosis was confirmed by Computed Tomography in 11 (45.4%), Ultrasonography in five (16.1%) and Computed Tomography with Ultrasonography in 15 (33.3%). Eight patients (25.8%) were evaluated as Type-1, 10 (32.2%) as Type-2 and 13 (41.9%) as Type-3. Mean International Normalized Ratio (INR) value of patients was 2.59. Bleeding was controlled by surgery in three cases (9.6%). The conservative approach was preferred in 28 cases (90.3%). 29 (93.5%) patients were discharged after an average hospital stay of 7.48 days (4-21). One patient died on the postoperative 5th day and other on the 14th day of conservative treatment (6.45% mortality). The mortality rate of conservatively and surgically treated patients was 3.5% and 33.3%, respectively. CONCLUSION: Rectus sheath hematoma should be suspected in elderly patients using anticoagulants with acute abdominal pain, severe cough attacks and an umbilical palpable or radiologically supported mass. Computed Tomography and Ultrasonography should be performed in case of clinical suspicion. Early and correct diagnosis ensures successful conservative treatment and prevents unnecessary surgical procedures. In the management of cases where clinician experience is at the forefront, we are hopeful that a new effective algorithm system and guidelines for the diagnosis will be identified after increasing the presentations of case series and experiences.
- 1 January 2021
- Published by Kare Publishing in Turkish Journal of Trauma and Emergency Surgery
- Vol. 27 (2) , 222-230
Open AccessTreatment of rectus sheath hematomas: 8 years of single center experience with a review of literature
BACKGROUND: Rectus sheath hematoma is a rare and frequently misdiagnosed cause of acute abdominal pain. In the management of the patients with rectus sheath hematoma, which are mostly with advanced age and comorbid diseases, positive results can be obtained by avoiding unnecessary surgical procedures with correct diagnosis and treatment approaches. The presented study aims to contribute to the lack of algorithms and optimal treatment strategies in the management of rectus sheath hematoma patients with the description of our experience in their management. METHODS: Patients who underwent treatment with the diagnosis of rectus sheath hematoma between May 2010 and July 2018 were retrospectively analyzed. Demographic characteristics, medical histories, physical and laboratory findings and imaging methods, treatment processes, complications, morbidity, mortality, length of hospitalization and long-term follow-up results were searched. Data were analyzed from patient files, hospital computer registry system and radiology archives. Data analysis was performed using Microsoft Excel and IBM-SPSS-Statistics-24. RESULTS: The mean age of the 31 patients was 63.03 years (24-85 years). The female/male ratio (21/10) was 2.1. The most common presenting sign or symptom was abdominal pain (100%), followed by abdominal wall mass in 25 patients (80.6%). Twenty-five patients (80.6%) were receiving some form of anticoagulation and antiplatelet therapy. Diagnosis was confirmed by Computed Tomography in 11 (45.4%), Ultrasonography in five (16.1%) and Computed Tomography with Ultrasonography in 15 (33.3%). Eight patients (25.8%) were evaluated as Type-1, 10 (32.2%) as Type-2 and 13 (41.9%) as Type-3. Mean International Normalized Ratio (INR) value of patients was 2.59. Bleeding was controlled by surgery in three cases (9.6%). The conservative approach was preferred in 28 cases (90.3%). 29 (93.5%) patients were discharged after an average hospital stay of 7.48 days (4-21). One patient died on the postoperative 5th day and other on the 14th day of conservative treatment (6.45% mortality). The mortality rate of conservatively and surgically treated patients was 3.5% and 33.3%, respectively. CONCLUSION: Rectus sheath hematoma should be suspected in elderly patients using anticoagulants with acute abdominal pain, severe cough attacks and an umbilical palpable or radiologically supported mass. Computed Tomography and Ultrasonography should be performed in case of clinical suspicion. Early and correct diagnosis ensures successful conservative treatment and prevents unnecessary surgical procedures. In the management of cases where clinician experience is at the forefront, we are hopeful that a new effective algorithm system and guidelines for the diagnosis will be identified after increasing the presentations of case series and experiences.